USPTO Office Action, and Myriad Genetics' Subsequent Response
Loading...
Date
1997
Journal Title
Journal ISSN
Volume Title
Abstract
Type
Department
Description
The USPTO requested that Myriad restrict its application to one invention, and suggested ways to group claims in distinct inventions; Myriad responded with alternate combinations of claims into fewer new distinct inventions.
Provenance
Subjects
Genetics, Myriad Genetics, BRCA, Breast Cancer, Gene Patents, Law, Health Policy, Medicine, Women’s Health
Citation
Permalink
Citation
United States Patent and Trade Office, and Inc. Myriad Genetics (1997). USPTO Office Action, and Myriad Genetics' Subsequent Response. Retrieved from https://hdl.handle.net/10161/7674.